Status:
ACTIVE_NOT_RECRUITING
Continuous Glucose Monitoring Following Hospital Discharge
Lead Sponsor:
Kathleen Dungan
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this 12-week prospective observational cohort study, hospitalized insulin-requiring patients with T2D will receive a Dexcom continuous glucose monitor (CGM) to wear post-hospital discharge. Patient...
Eligibility Criteria
Inclusion
- Type 2 Diabetes
- Basal insulin use \>10 units per day
- Hemoglobin A1c \>8.0%
- Smartphone compatible with Clarity App
- Age ≥18 years
Exclusion
- Type 1 DM
- Inability to consent
- Pregnancy
- Prisoners
- Discharge to skilled nursing facility
Key Trial Info
Start Date :
April 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT05360056
Start Date
April 26 2022
End Date
December 1 2025
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University Medical Center - Outpatient Care East
Columbus, Ohio, United States, 43203